The best-performing state secondary schools in England for 2025 have been revealed - find out how local schools in your area ...
TipRanks on MSN
Genentech presents new Phase 3 data for vamikibart
G enentech, a member of the Roche Group, announced results from two Phase III studies evaluating the efficacy and safety of two doses of investigational vamikibart compared with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback